HOWL (Werewolf Therapeutics, Inc. Common Stock) Stock Analysis - AI Report
Werewolf Therapeutics, Inc. Common Stock (HOWL) is a publicly traded Healthcare sector company. As of May 21, 2026, HOWL trades at $0.44 with a market cap of $24.07M and a P/E ratio of -0.34. HOWL moved +3.43% today. Year to date, HOWL is -32.03%; over the trailing twelve months it is -61.58%. Its 52-week range spans $0.40 to $4.18. Rallies surfaces HOWL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What is the AI research view on HOWL?
Rallies AI research for HOWL combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
EVNIN LUKE sold 85.89K (~$36.93K) on May 20, 2026.
EVNIN LUKE sold 62.97K (~$28.34K) on May 19, 2026.
EVNIN LUKE sold 22.18K (~$11.09K) on May 18, 2026.
HOWL Analyst Consensus
HOWL analyst coverage data. Average price target: $0.00.
Common questions about HOWL
What is the AI research view on HOWL?
Rallies AI research for HOWL combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for HOWL?
Rallies AI research for HOWL combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is HOWL research on Rallies investment advice?
No. Rallies provides research, data, and educational context for HOWL. It does not provide personalized investment advice.
